IEX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
IDEX Corp (IEX) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock shows strong fundamentals, positive analyst sentiment, and improving financial performance, making it a solid choice for long-term growth.
The stock's technical indicators present a mixed picture. The MACD histogram is negative and contracting, suggesting a weakening momentum. However, the RSI is neutral at 57.967, and the moving averages are bullish (SMA_5 > SMA_20 > SMA_200). The stock is trading near its pivot level of 208.888, with support at 204.996 and resistance at 212.781. Overall, the technicals lean slightly bullish.
Analysts have consistently raised price targets, with the latest targets ranging from $230 to $250, indicating strong confidence in the stock's future performance.
The company's Q4 2025 financials show solid growth, with revenue, net income, EPS, and gross margin all improving YoY.
Health and Science Technologies segment is driving strong order growth, with a 34% increase in organic orders.
Potential macroeconomic catalysts for 2026, such as lower interest rates and U.S. government actions, could further benefit the company.
The MACD indicator suggests weakening momentum, which could indicate short-term price pressure.
The stock's post-market price dropped by 0.85%, which may reflect some immediate selling pressure.
No recent news or significant insider/hedge fund activity to provide additional confidence.
In Q4 2025, IDEX Corp reported strong financial performance: Revenue increased by 4.20% YoY to $899.1M, Net Income rose by 4.14% YoY to $128.3M, EPS grew by 5.56% YoY to 1.71, and Gross Margin improved by 1.20% YoY to 43.05%. These metrics indicate healthy growth and operational efficiency.
Analysts are highly positive on IDEX Corp, with multiple firms raising price targets and maintaining Buy or Outperform ratings. Recent upgrades highlight strong Q4 performance, robust order growth in key segments, and an optimistic outlook for 2026. Price targets range from $230 to $250, reflecting significant upside potential from the current price of $207.81.
